Pricing Log in Create free account

Rockwell Medical, Inc. (RMTI) vs Zhengye Biotechnology Holding Limited (ZYBT)

Rockwell Medical, Inc. and Zhengye Biotechnology Holding Limited are both Drug Manufacturers Specialty & Generic companies. Zhengye Biotechnology Holding Limited is the larger, with a market value of $41.0M against $30.6M — 1.3× the size. Across the 9 metrics below, Zhengye Biotechnology Holding Limited leads on 7 and Rockwell Medical, Inc. on 2.

Valuation

Metric RMTI ZYBT Drug Manufacturers Specialty & Generic median
P/E n/m — 20.55
P/S 0.44 — 2.08
P/B 0.87 n/m 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales 0.21 n/m 2.87
Earnings yield (17.40%) — (15.94%)
Free cash flow yield (3.22%) 0.00% 0.00%

Profitability

Metric RMTI ZYBT Drug Manufacturers Specialty & Generic median
Gross margin 17.71% — 53.51%
Operating margin (6.52%) — 0.00%
Net margin (7.33%) — (2.45%)
Free cash flow margin 2.47% 0.00% 0.00%
Return on equity (15.53%) 0.00% (0.80%)
Return on assets (9.32%) 0.00% (1.67%)
Return on invested capital (14.58%) 0.00% 0.00%

Growth

Metric RMTI ZYBT Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (21.12%) — 5.22%
EPS growth (last fiscal year) (870.87%) (800.00%) 42.91%
Revenue growth, 5-year CAGR 2.17% — 7.24%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric RMTI ZYBT Drug Manufacturers Specialty & Generic median
Debt to equity 0.26 0.24 0.04
Current ratio 3.25 1.14 2.41
Net debt to EBITDA 7.40 (0.51) 1.01

Dividend

Metric RMTI ZYBT Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric RMTI ZYBT Drug Manufacturers Specialty & Generic median
Market cap 30.64m 41.02m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack